Stock Report

All about this stock under one free report Last Updated: 12-Nov-2026

Stock Rating

Is this stock worth it? Our ratings reveal the truth.

Wealth Insight New Issue

Serious stock insights. No fluff. No FOMO.

Recently Viewed

Titan Bio-Tech Key Ratios

Stock Card factsheet watchlist-stock-modal share-fund-plan-icon

BSE: 524717

₹372.60

up-down-arrow ₹3.90 (1.06%)

As on 12-Nov-2026 14:32IST

Market cap

info icon

₹1,938 Cr

Revenue (TTM)

info icon

₹241 Cr

P/E Ratio

info icon

50.1

P/B Ratio

info icon

9.5

Div. Yield

info icon

0.1 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue 29.23 40.67 38.25 18.36 9.42
EBIT 23.09 68.59 85.26 20.33 1.65
Net Profit 15.59 61.62 67.64 22.77 8.45
EPS 15.58 61.59 67.62 22.77 8.68
Book Value -- -- 18.35 18.21 21.43
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsTTMMar-26Mar-25
EBIT-Margin info 16.2618.1717.7516.3313.59
Net Margin info 12.8814.0914.2112.9711.39
Return on equity info 16.9719.6020.1216.3912.74
Return on Capital info 22.8025.30--22.9417.00
Return on Assets info 13.7315.0315.7213.6210.58
Debt to Equity (x) info ----0.000.020.01

Profitability

View Detailed Peer Comparison

ROCE

--

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Titan Bio-Tech
--
22.94
17.00
25.39
27.40
Peer Median
--
13.17
10.67
24.98
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROE

20.12

Higher than Peers by 9.72

Profit after tax / Average Net worth * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Titan Bio-Tech
20.12
16.39
12.74
19.45
21.44
Peer Median
10.40
10.29
7.59
20.21
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROA

15.72

Higher than Peers by 9.30

Profit after tax / Average Total assets * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Titan Bio-Tech
15.72
13.62
10.58
15.44
16.37
Peer Median
6.42
6.40
5.44
12.91
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Margin

17.75

Higher than Peers by 6.79

Operating profit (EBIT) / Net Sales * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Titan Bio-Tech
17.75
16.33
13.59
18.86
18.69
Peer Median
10.97
10.60
11.66
11.54
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Margin

14.21

Higher than Peers by 6.38

Net profit / Total Income (Net sales plus other income) * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Titan Bio-Tech
14.21
12.97
11.39
14.27
14.41
Peer Median
7.82
7.09
7.57
9.71
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Profit Margin

--

--

(Net profit + Depreciation) / Gross Sales * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Titan Bio-Tech
--
15.70
14.34
16.45
16.41
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Growth

View Detailed Peer Comparison

Revenue Growth

38.25

Higher than Peers by 31.77

Year on year growth in net sales

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Titan Bio-Tech
38.25
31.79
-4.65
13.94
16.55
Peer Median
6.48
14.63
9.11
-10.85
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Growth

85.26

Higher than Peers by 87.06

Year on year growth in operating profit (EBIT)

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Titan Bio-Tech
85.26
58.44
-31.32
14.98
-6.86
Peer Median
-1.81
26.84
6.88
-32.98
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Profit Growth

67.64

Higher than Peers by 64.79

Year on year growth in profit after tax

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Titan Bio-Tech
67.64
50.22
-22.79
12.55
-3.04
Peer Median
2.85
38.05
16.56
-31.20
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EPS Growth

67.62

Higher than Peers by 66.92

Year on year growth in earnings per share

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Titan Bio-Tech
67.62
38.80
-13.36
0.04
14.57
Peer Median
0.71
24.45
20.92
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Book Value Growth

--

--

Year on year growth in book value per share

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Titan Bio-Tech
--
18.35
14.95
21.42
27.44
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Solvency

View Detailed Peer Comparison

Debt to Equity

0.00

Lower than Peers by 0.04

Total debt / Net worth

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Titan Bio-Tech
0.00
0.02
0.01
0.05
0.06
Peer Median
0.05
0.25
0.07
0.15
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Short term debt to equity ratio

--

--

(Short term borrowings / Net worth)

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Titan Bio-Tech
--
0.02
0.01
0.05
0.05
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Current Ratio

3.05

Higher than Peers by 1.35

Current Assets / Current Liabilities and Provisions

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Titan Bio-Tech
3.05
2.71
3.61
2.94
2.74
Peer Median
1.70
1.68
1.68
1.57
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Quick Ratio

1.28

Higher than Peers by 0.27

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Titan Bio-Tech
1.28
1.10
1.46
1.27
1.43
Peer Median
1.00
1.08
1.31
1.19
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Interest Coverage

51.06

Higher than Peers by 40.95

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Titan Bio-Tech
51.06
42.77
31.39
27.95
38.69
Peer Median
10.10
7.60
7.47
19.21
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

11.27

Lower than Peers by 2.14

Debtors outstanding / Net Sales * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Titan Bio-Tech
11.27
11.07
12.03
11.37
14.59
Peer Median
13.41
14.80
14.65
12.34
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Asset Turnover

1.08

Higher than Peers by 0.29

Sales / Average Total Assets

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Titan Bio-Tech
1.08
1.02
0.91
1.07
1.12
Peer Median
0.79
0.82
0.86
0.92
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Receivable days

--

--

Average Debtors / Sales * 365

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Titan Bio-Tech
--
36.86
43.71
44.12
47.36
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Inventory Days

--

--

Average Inventory / Sales * 365

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Titan Bio-Tech
--
94.34
112.44
90.92
89.79
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Payable days

--

--

Average Creditors / Cost of goods sold * 365

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Titan Bio-Tech
--
30.76
27.70
21.53
25.39
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Conversion Cycle

--

--

Receivable Days + Inventory Days - Payable Days

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Titan Bio-Tech
--
100.44
128.45
113.51
111.76
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Valuation

View Detailed Peer Comparison

Price / Earnings

50.11

Higher than Peers by 28.38

Current share price divided by earning per share in the last twelve months

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Titan Bio-Tech
50.11
63.28
3.24
17.56
6.55
Peer Median
21.74
23.16
40.01
28.36
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Price / Book Value

9.46

Higher than Peers by 7.74

Current share price divided by book value per share in the latest financial year

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Titan Bio-Tech
9.46
10.42
2.27
3.27
1.48
Peer Median
1.72
1.67
1.93
2.13
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Dividend Yield

0.11

Lower than Peers by 0.30

Dividend per share in the past twelve months divided by current share price

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Titan Bio-Tech
0.11
0.11
0.47
0.38
0.91
Peer Median
0.40
0.40
0.27
0.45
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EV/EBITDA

35.26

--

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Titan Bio-Tech
35.26
43.01
11.76
12.22
5.24
Peer Median
--
18.03
22.60
12.16
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Market Cap

1,938

Higher than Peers by 33

Current Share price multiplied by latest total number of shares outstanding

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Titan Bio-Tech
1,938
1,891
348
436
163
Peer Median
1,904
1,491
1,454
1,457
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
loading...
loading...
loading...

Informed fund ideas, better judgment. Every month. Mutual Fund Insight, every month since October 2002.

Take charge. Know more. Keep more. Mutual Fund Insight helps you do all three — every month